Sanofi ADS (SNY)
SNY trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$39.12
-1.56% on the day
Market cap
$95.4B
Large cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | SNY on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | France |
| IPO year | Not reported by the screener |
| SEC CIK | 0001121404 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | I0 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-10-29 |
| Latest annual report | 20-F | 2026-02-17 |
| Latest quarterly / interim | 6-K | 2026-10-01 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.1% |
| 1 month | -6.2% |
| 3 months | -10.0% |
| Year to date | -17.9% |
| 1 year | -18.5% |
| From 52-week high | -24.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GSK | GSK plc | $46.27 | -1.39% | $93.6B |
| BMY | Bristol-Myers Squibb Company | $56.67 | -1.58% | $115.8B |
| REGN | Regeneron Pharmaceuticals Inc. | $753.12 | -1.27% | $77.5B |
| VRTX | Vertex Pharmaceuticals Incorporated | $485.22 | -4.30% | $123.0B |
| TAK | Takeda Pharmaceutical Company Limited | $18.52 | -0.86% | $58.5B |
| PFE | Pfizer Inc. | $28.37 | -0.11% | $161.7B |
| NVO | Novo Nordisk A/S | $38.06 | -1.35% | $168.5B |
| ABT | Abbott Laboratories | $102.61 | +0.78% | $177.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier